Figure 3.
Landmark analysis according to molecular response categories in patients with MMR 3 months after 2G-TKI discontinuation. (A) Cumulative incidence of relapse and overall P value (Gray’s test) are shown. (B) TFR and overall P value (log rank) are shown.